MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Sunrest Lifescience Ltd
SU
Sunrest Lifescience Ltd
CLOSED NSE SME Fixed Price IPO Fresh Capital Sunrest Lifescience IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹84
Issue Price: ₹ 84
Issue Price
₹84
Face Value
₹10
Lot Size
1,600 shares
Open Date
07 Nov 2023
Close Date
09 Nov 2023
Allotment
15 Nov 2023
Listing Date
20 Nov 2023
Exchange
NSE SME
Sunrest Lifescience IPO About the Company

Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.

The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.

The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.

Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.

With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.

...read more
Sunrest Lifescience IPO Objects of the Issue
Purpose Amount (₹ Cr)
Meeting Working Capital Requirements ₹9
General Corporate Purpose ₹1
Sunrest Lifescience IPO Lead Managers
Mark Corporate Advisors Pvt.Ltd
Financial Summary Amount in ₹ Lakhs
Metric 30 Jun 2023 31 Mar 2023 31 Mar 2022
Total Assets 1,706 1,671 1,302
Revenue 564 2,467 2,691
PAT 75 204 78
Net Worth 387 312 107
Reserves 87 12 106
Total Borrowing 347 214 324
Sunrest Lifescience IPO Key Financial Ratios
ROE
53
ROCE
98
RONW
66
Debt/Equity
1
Issue Details
Total Shares Offered
1,291,200 (100%)
Reserved for Market Maker
Up to ₹1 Cr
Net Offer to Public
Up to ₹10 Cr
Pre-Issue Shareholding
3,000,000 shares
Post-Issue Shareholding
4,291,200 shares
UPI Mandate
09 Nov 2023
IPO Analytics Dashboard
LIVE
Sunrest Lifescience IPO GMP Insights
👤
Retail Demand
Strong
💼
HNI Interest
Strong
📊
Valuation
Strong
Sunrest Lifescience IPO GMP Strength Score
9 / 10 Strong
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Sunrest Lifescience IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
💼 NII / HNI — 612,800 (47%) —
👤 Retail (RII) — 612,800 (47%) —
📊 Market Maker — 65,600 (5%) —
Σ Total — 1,291,200 (100%) —

* Amount calculated at upper price band (₹84) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
💼
NII / HNI ? 612,800 (47%)
47%
👤
Retail (RII) ? 612,800 (47%)
47%
📊
Market Maker ? 65,600 (5%)
5%
Total Shares Offered 1,291,200 (100%)
Sunrest Lifescience IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 1,600
Min. Investment ₹134,400
💼 HNI Investors ?
Min. Lots 2
Min. Shares 3,200
Min. Investment ₹268,800
Sunrest Lifescience IPO Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue EPS ?
₹ 7
Pre-Issue P/E ?
12 x
Post-Issue P/E ?
12 x
Sunrest Lifescience IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 16 Nov 2023
  2. 2 📂 Credit of Shares to Demat 17 Nov 2023
Investor Interpretation
  • Retail allocation is strong at 47% of the total offering.
  • HNI/NII demand is strong at 47%.
  • The IPO P/E of 12x reflects a strong valuation relative to typical market ranges.
  • Pre-issue EPS of ₹7.

This IPO shows strong fundamentals and healthy investor demand. Research the business model and compare with sector peers before applying.

STOCK PRICE HISTORY  ·  NSE
—
Issue Price: ₹ 84  ·  Symbol: —
H —
L —
O —
Sunrest Lifescience IPO Company Info
📍 FF-41, Ajay Tenament-6, Near Canal Near Ritanagar, Bus Stand Vastral Road, Ahmedabad, Gujarat, 382415
Visit Website
Sunrest Lifescience IPO Registrar
Skyline Financial Services Pvt.Ltd.
Check Allotment Status
Sunrest Lifescience IPO FAQs
Sunrest Lifescience IPO has already listed. Its last recorded GMP was ₹0. GMP is only indicative and never a guarantee of listing gains.
The issue price of Sunrest Lifescience IPO is ₹84 per share. One lot has 1,600 shares, so the minimum investment is about ₹134,400. It is a Fresh Capital issue.
Sunrest Lifescience IPO opened on 07 Nov 2023 and closed on 09 Nov 2023. Allotment is tentatively finalised on 15 Nov 2023. Shares are listed on NSE SME on 20 Nov 2023.
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste.
As per the offer document, Sunrest Lifescience plans to use the IPO proceeds for: Meeting Working Capital Requirements (₹9); General Corporate Purpose (₹1).
The lead manager of Sunrest Lifescience IPO is Mark Corporate Advisors Pvt.Ltd.
Sunrest Lifescience IPO is proposed to list on NSE SME; it is a Fixed Price IPO and the issue is a Fresh Capital.
Disclaimer

The information on mainboardgmp.com is provided for educational and informational purposes only.

We are not a Securities and Exchange Board of India (SEBI)-registered investment advisor, analyst, broker, or financial planner. The content, data, and insights on this website, including Grey Market Premium (GMP), subscription data, IPO dates, and market information, are not intended as financial advice or recommendations to buy, sell, or hold securities.

GMP and related IPO data are collected from unofficial market sources and may not reflect actual IPO listing performance or future price movements. You should not rely solely on the information provided here to make financial or investment decisions.

Investing in IPOs and securities involves risk. Always conduct your own research and consult a qualified SEBI-registered financial advisor before making investment decisions. mainboardgmp.com and its owners shall not be liable for any financial losses, trading losses, or damages arising from use of this website.

By using this website, you acknowledge and agree that you use the content at your own risk.